J Appl Biomed 16:66-74, 2018 | DOI: 10.1016/j.jab.2017.10.008

DNA repair inhibitors as radiosensitizers in human lung cells

Kamila Ďurišováa, Lucie Čechákováa, Petr Joštb,c, Zuzana Šinkorováa, Adéla Kmochováa, Jaroslav Pejchala,b, Martin Ondreja, Jiřina Vávrováa, Aleš Tichýa,c,*
a University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
b University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
c University Hospital Hradec Králové, Biomedical Research Centre, Hradec Králové, Czech Republic

The aim of this study was to compare the effects of DNA repair inhibitors in the context of radio-sensitization of human lung cells. The radio-sensitizing effects of NU7441 (1 mM), an inhibitor of DNA-dependent protein kinase (DNA-PK); KU55933 (10 μM), an inhibitor of ataxia-telangiectasia mutated kinase (ATM); and VE-821 (10 μM), an inhibitor of ATM-related kinase (ATR) were tested by the xCELLigence system for monitoring proliferation, fluorescence microscopy for DNA damage detection, flow-cytometry for cell cycle and apoptosis analysis and western blotting and ELISA for determination of DNA repair proteins. We employed normal human lung fibroblasts (NHLF, p53-wild-type) and non-small cell lung cancer cells (H1299, p53-negative). DNA-PK inhibition (by NU7441) in combination with ionizing radiation (IR) increased the number of double strand breaks (DSB), which persisted 72 h after irradiation in both cell lines. Additionally, NU7441 and KU55933 in combination with IR caused G2-arrest. ATR inhibitor (VE-821) together with IR markedly inhibited proliferation and induced G2/M arrest accompanied by apoptosis in H1299, but not in NHLF cells, and thus diminished DNA-repair of tumour cells but not normal lung fibroblasts. Our findings indicate that ATR inhibition could be a promising therapeutic strategy in p53-deficient lung tumours.

Keywords: DNA repair; DNA-PK; ATM; ATR; Inhibition; Ionizing radiation; Lung cancer

Received: December 12, 2016; Revised: May 23, 2017; Accepted: October 24, 2017; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ďurišová K, Čecháková L, Jošt P, Šinkorová Z, Kmochová A, Pejchal J, et al.. DNA repair inhibitors as radiosensitizers in human lung cells. J Appl Biomed. 2018;16(1):66-74. doi: 10.1016/j.jab.2017.10.008.
Download citation

References

  1. Ćmielová, J., Havelek, R., Vávrová, J., Řezáčová, M., 2015. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition. Med. Oncol. 32, 138. Go to original source... Go to PubMed...
  2. Allen, C., Halbrook, J., Nickoloff, J.A., 2003. Interactive competition between homologous recombination and non-homologous end joining. Mol. Cancer Res. 1, 913-920.
  3. An, B., Goldfarb, R.H., Siman, R., Dou, Q.P., 1998. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed but not normal, human fibroblasts. Cell Death Differ. 5, 1062-1075. Go to original source... Go to PubMed...
  4. Andrs, M., Korabecny, J., Jun, D., Hodny, Z., Bartek, J., Kuca, K., 2015. Phosphatidylinositol 3-Kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring. J. Med. Chem. 58, 41-71. Go to original source... Go to PubMed...
  5. Baumann, P., West, S.C., 1998. DNA end-joining catalyzed by human cell-free extracts. PNAS 95, 14066-14070. Go to original source... Go to PubMed...
  6. Chaturvedi, P., Eng, W.K., Zhu, Y., Mattern, M.R., Mishra, R., Hurle, M.R., et al., 1999. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047-4054. Go to original source... Go to PubMed...
  7. Christodoulou, M., Bayman, N., McCloskey, P., Rowbottom, C., Faivre-Finn, C., 2014. New radiotherapy approaches in locally advanced non-small cell lung cancer. Eur. J. Cancer 50, 525-534. Go to original source... Go to PubMed...
  8. Ciszewski, W.M., Tavecchio, M., Dastych, J., Curtin, N.J., 2014. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res. Treat. 143, 47-55. Go to original source... Go to PubMed...
  9. Fuks, Z., Persaud, R.S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwartz, J.L., et al., 1994. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54, 2582-2590.
  10. Gérard, C., Debruyne, C., 2009. Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer. Mol. Oncol. 3, 409-424. Go to original source... Go to PubMed...
  11. Gatei, M., Sloper, K., Sorensen, C., Syljuäsen, R., Falck, J., Hobson, K., et al., 2003. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278, 14806-14811. Go to original source... Go to PubMed...
  12. Giunta, S., Belotserkovskaya, R., Jackson, S.P., 2010. DNA damage signaling in response to double-strand breaks during mitosis. J. Cell Biol. 190, 197-207. Go to original source...
  13. Gorbunova, V., Seluanov, A., Pereira-Smith, O.M., 2002. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277, 38540-38549. Go to original source... Go to PubMed...
  14. Hirao, A., Kong, Y.Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., et al., 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827. Go to original source... Go to PubMed...
  15. Hurley, P.J., Wilsker, D., Bunz, F., 2007. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene 26, 2535-2542. Go to original source... Go to PubMed...
  16. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C.M., Lukas, J., Jackson, S.P., 2006. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37-45. Go to original source... Go to PubMed...
  17. Ke, N., Wang, X., Xu, X., Abassi, Y.A., 2011. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 740, 33-43. Go to original source... Go to PubMed...
  18. Kmochova, A., Tichy, A., Zarybnicka, L., Sinkorova, Z., Vavrova, J., Rehacek, V., et al., 2016. Modulation of ionizing radiation-induced effects by NU7441, KU55933 and VE821 in peripheral blood lymphocytes. J Appl. Biomed. 14, 19-24. Go to original source...
  19. Lane, D.P., 1992. Cancer. p53 guardian of the genome. Nature 358, 15-16. Go to original source... Go to PubMed...
  20. Liu, S., Opiyo, S.O., Manthey, K., Glanzer, J.G., Ashley, A.K., Amerin, C., et al., 2012. Distinct roles for DNA-PK: ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res. 40, 10780-10794. Go to original source... Go to PubMed...
  21. Nikitaki, Z., Michalopoulos, I., Georgakilas, A.G., 2015. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon. Future Med Chem. 7, 1543-1558. Go to original source... Go to PubMed...
  22. Parsels, L.A., Qian, Y., Tanska, D.M., Gross, M., Zhao, L., Hassan, M.C., et al., 2011. Assessment of Chk1 phosphorylation as a pharmacodynamic biomarker of Chk1 inhibition. Clin. Cancer Res. 17, 3706-3715. Go to original source... Go to PubMed...
  23. Peddi, P., Loftin, C.W., Dickey, J.S., Hair, J.M., Burns, K.J., Aziz, K., et al., 2010. DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radic. Biol. Med. 48, 1435-1443. Go to original source... Go to PubMed...
  24. Pires, I.M., Olcina, M.M., Anbalagan, S., Pollard, J.R., Reaper, P.M., Charlton, P.A., et al., 2012. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition. Br. J. Cancer 107, 291-299. Go to original source... Go to PubMed...
  25. Reaper, P.M., Griffiths, M.R., Long, J.M., Charrier, J.-D., Maccormick, S., Charlton, P.A., et al., 2011. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nat. Chem. Biol. 7, 428-430. Go to original source... Go to PubMed...
  26. Schiller, J.H., Harrington, D., Belani, C.P., Langer, C., Sandler, A., Krook, J., et al., 2002. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Engl. J. Med. 346, 92-98. Go to original source... Go to PubMed...
  27. Taylor, W.R., Stark, G.R., 2001. Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815. Go to original source... Go to PubMed...
  28. Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.-Y., et al., 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157. Go to original source... Go to PubMed...
  29. Tichy, A., Durisova, K., Salovska, B., Pejchal, J., Zarybnicka, L., Vavrova, J., et al., 2014. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Radiat. Environ. Biophys. 53, 83-92. Go to original source... Go to PubMed...
  30. Toledo, L.I., Altmeyer, M., Rask, M.-B., Lukas, C., Larsen, D.H., Povlsen, L.K., et al., 2013. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088-1103. Go to original source... Go to PubMed...
  31. Vávrová, J., Zárybnická, L., Lukášová, E., Řezáčová, M., Novotná, E., Sinkorová, Z., et al., 2013. Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60). Radiat. Environ. Biophys. 52, 471-479. Go to original source... Go to PubMed...
  32. Wang, X.Q., Redpath, J.L., Fan, S.T., Stanbridge, E.J., 2006. ATR dependent activation of Chk2. J. Cell. Physiol. 208, 613-619. Go to original source... Go to PubMed...
  33. Zhao, H., Watkins, J.L., Piwnica-Worms, H., 2002. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. PNAS 99, 14795-14800. Go to original source... Go to PubMed...
  34. Zhuang, L., Cao, Y., Xiong, H., Gao, Q., Cao, Z., Liu, F., et al., 2011. Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells. Int. J. Oncol. 39, 443-451. Go to original source... Go to PubMed...